Article
Tumor suppressor PTEN in breast cancer: heterozygosity, mutations and protein expression.
Anticancer research - 1 Mar 2014
Kechagioglou Petros, Papi Rigini M, Provatopoulou Xeni, Kalogera Eleni, Papadimitriou Elli, Grigoropoulos Petros, Nonni Aphroditi, Zografos George, Kyriakidis Dimitrios A, Gounaris Antonia
Abstract excerpt
Phosphatase and tensin homolog deleted on chromosome ten (PTEN) is one of the most frequently mutated human tumor suppressor genes, implicated in cell growth and survival and suppressing tumor formation. Loss of PTEN activity, either at the protein or genomic level, has been related to many primary and metastatic malignancies including breast cancer. The present study investigates the heterozygosity, mutation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
